Sign up USA
Proactive Investors - Run By Investors For Investors

Pressure BioSciences has an eye toward uplisting as it strengthens balance sheet

Pressure BioSciences (OTCMKTS:PBIO, OTCQB: PBIO) CEO Ric Schumacher tells Proactive Investors the life sciences company has strengthened its balance sheet with the conversion of an additional $7.24mln of debt into equity, bringing the total amount of debt that has converted into equity over the past four weeks to more than $13.6mln.

Schumacher says the company is on track to uplist to a national exchange, and would like to make the move by the end of the year.

 
Meet Legend Mining Ltd, Nexus Minerals Ltd, Tyranna Resources Ltd and Global Health Ltd at our event, Sydney , 23 July 2018. Register here »
View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use